Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health-Related Quality-of-Life and Health-Care Resource Utilization Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies

NCT01178346 is registered in ClinicalTrials.gov with Nabi Biopharmaceuticals as lead sponsor.

NCT NCT01178346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01178346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health-Related Quality-of-Life and Health-Care Resource Utilization Assessment in Nabi-4514 and Nabi-4515 Phase 3 Studies
Lead sponsor
Nabi Biopharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2010
Completion date
November 30, 2011
Enrollment
500 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation